Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
RINCON-RIANO, Diana Nathalie; FERNANDEZ-AVILA, Daniel G. and GUTIERREZ, Juan M.. Leflunomide-induced Stevens Johnson syndrome in a patient with systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2017, vol.24, n.4, pp.242-246. ISSN 0121-8123.
Leflunomide is an immunomodulatory agent widely used in rheumatoid arthritis and other rheumatic diseases like psoriatic arthritis and systemic lupus erythematosus. Although its safety profile is generally good, side effects have been reported in up to 20% of cases. Severe reactions, such as toxic epidermal necrolysis and Stevens Johnson syndrome are rare. The case is presented of a leflunomide-induced Stevens Johnson syndrome in a patient with systemic lupus erythematosus.
Keywords : Leflunomide; Stevens-Johnson syndrome; Adverse effects.